MFN1 and hepatocellular carcinoma: Mechanistically, MFN1 induces the transition of HCC from an aerobic glycolytic phenotype to an OXPHOS phenotype by affecting the expression of glycolytic and oxidative phosphorylation enzymes, thereby inhibiting HCC progression (99).